- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Aprea Therapeutics is a biotechnology business based in the US. Aprea Therapeutics shares (APRE) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.26 – a decrease of 6.5% over the previous week. Aprea Therapeutics employs 7 staff and has a trailing 12-month revenue of around $1.3 million.
What's in this guide?
Our top picks for where to buy Aprea Therapeutics stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Aprea Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – APRE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Aprea Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 5 of 5
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Aprea Therapeutics stock price (NASDAQ: APRE)
Use our graph to track the performance of APRE stocks over time.Aprea Therapeutics shares at a glance
Information last updated 2024-12-12.
| Latest market close | $3.26 |
|---|---|
| 52-week range | $2.15 - $8.85 |
| 50-day moving average | $3.36 |
| 200-day moving average | $4.38 |
| Wall St. target price | $15.67 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-2.80 |
Is it a good time to buy Aprea Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aprea Therapeutics price performance over time
Historical closes compared with the close of $3.195 from 2024-12-13
| 1 week (2024-12-09) | -10.50% |
|---|---|
| 1 month (2024-11-15) | -1.69% |
| 3 months (2024-09-16) | 3.57% |
| 6 months (2024-06-14) | -27.48% |
| 1 year (2023-12-15) | -16.80% |
|---|---|
| 2 years (2022-12-16) | -50.08% |
| 3 years (2021-12-16) | 65.2 |
| 5 years (2019-12-16) | 666 |
Aprea Therapeutics financials
| Revenue TTM | $1.3 million |
|---|---|
| Gross profit TTM | $0 |
| Return on assets TTM | -30.26% |
| Return on equity TTM | -50.11% |
| Profit margin | 0% |
| Book value | $4.54 |
| Market Capitalization | $19.6 million |
TTM: trailing 12 months
Aprea Therapeutics share dividends
We're not expecting Aprea Therapeutics to pay a dividend over the next 12 months.
Have Aprea Therapeutics's shares ever split?
Aprea Therapeutics's shares were split on a 1:20 basis on 12 February 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aprea Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Aprea Therapeutics shares which in turn could have impacted Aprea Therapeutics's share price.
Aprea Therapeutics share price volatility
Over the last 12 months, Aprea Therapeutics's shares have ranged in value from as little as $2.1501 up to $8.8465. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aprea Therapeutics's is 1.735. This would suggest that Aprea Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Aprea Therapeutics overview
Aprea Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania. .
Frequently asked questions
What percentage of Aprea Therapeutics is owned by insiders or institutions?Currently 11.75% of Aprea Therapeutics shares are held by insiders and 43.847% by institutions. How many people work for Aprea Therapeutics?
Latest data suggests 7 work at Aprea Therapeutics. When does the fiscal year end for Aprea Therapeutics?
Aprea Therapeutics's fiscal year ends in December. Where is Aprea Therapeutics based?
Aprea Therapeutics's address is: 3805 Old Easton Road, Doylestown, PA, United States, 18902 What is Aprea Therapeutics's ISIN number?
Aprea Therapeutics's international securities identification number is: US03836J1025 What is Aprea Therapeutics's CUSIP number?
Aprea Therapeutics's Committee on Uniform Securities Identification Procedures number is: 03836J102
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question